Lifespan

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Lifespan sits in the top decile of US sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count).

18 total trials 3 currently recruiting 11 completed later-stage tilt top decile by trial count

Lifespan: 18 sponsored US clinical trials, 3 recruiting.

Lifespan sponsors 18 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 11 completed. 3 of these trials are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Rotavirus Gastroenteritis, with 1 trials.

Top-decile sponsor footprint

Lifespan ranks in the top decile of sponsors by registered trial count (#801 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

A 90/100

11 of 11 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

18 total, page 1 of 1

RECRUITING Phase 4

Injectable Buprenorphine in Prison: A Preference Trial

NCT06880718

RECRUITING Phase 4

Implementing Low-Barrier HCV Treatment in a Jail Setting

NCT06953479

RECRUITING

Injectable Extended-Release Buprenorphine (XR-B) in a Correctional Setting: Qualitative Interviews

NCT06354465

ACTIVE NOT RECRUITING NA

TMS for PTSD and Blood Pressure

NCT05512143

ACTIVE NOT RECRUITING NA

Reducing Alcohol Use and Sexual Dysfunction in Survivors of Sexual Trauma

NCT05599620

ACTIVE NOT RECRUITING NA

Mindfulness & Mechanisms Study

NCT04626245

NOT YET RECRUITING NA

Stress Reactivity and Mother-Infant Cardiovascular Disease Risk

NCT06805799

COMPLETED NA

Prenatal Mindfulness & Hypertension Study

NCT03679117

COMPLETED Phase 3

Hydroxyurea Optimization Through Precision Study

NCT03789591

COMPLETED Early Phase 1

Medication Maintenance Therapy in Community Pharmacy Settings

NCT03766893

COMPLETED NA

Community Level Primary Prevention of Dating and Sexual Violence in Middle Schools

NCT03473067

COMPLETED NA

Buckle Me Up!: A Digital Emergency Department Discharge Intervention for Child Car Safety

NCT03799393

COMPLETED NA

Modulating Impulsivity in Suicidal Adolescents With Transcranial Direct Current Stimulation (tDCS)

NCT03365102

COMPLETED NA

Evaluating the Effectiveness of Incentive Spirometry

NCT02952027

COMPLETED NA

POCUS Assessment of Bladder Fullness for Girls Awaiting Radiology-Performed Transabdominal Pelvic Ultrasound

NCT02923245

COMPLETED NA

Preventing Sexual Aggression Among High School Boys

NCT02506088

COMPLETED NA

Integrated Alcohol and Sexual Assault Intervention for College Men

NCT05773027

COMPLETED

Rotavirus Gastroenteritis and Vaccine Usage in Rhode Island

NCT01026779

Where Lifespan enrollment is open (later-stage tilt)

3 recruiting of 18 indexed (17% open); 11 completed (61%).

Phase mix: 3 late (III/IV) vs 1 early (I/II) (later-stage heavy).

Top condition: Rotavirus Gastroenteritis (1 trial), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Lifespan: open-pipeline peers nationwide

Peers matched on 18 registered trials and 17% open enrollment, not the therapeutic-area sidebar.

Lifespan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 5101520 0%10%20%30%40% Total trials Recruiting share LifespanADC Therapeutics S.A.Akros PharmaAO Clinical Investigation and Publishing DocumentationAO Innovation Translation CenterAdageneAgendiaAkamis BioAngiodynamics
Lifespan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Lifespan sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 18 trials (± recruiting share)

Sponsors near 17% open enrollment (± trial volume)

What to do with this Lifespan page

18 registered trials is a research-attention snapshot, not an endorsement of Lifespan or any single study.

  • 3 of Lifespan's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Rotavirus Gastroenteritis is the condition Lifespan studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Rotavirus Gastroenteritis trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Lifespan pipeline card: 18 registered trials from official public datasets.Report a data error.